Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA3 | P07451 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 2/20 | 0.53 |
| ▸ | CA6 | P23280 | 2/20 | 0.53 |
| ▸ | CA5A | P35218 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28300321 | 1.00 | CHRM2 (0.55) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL817873 | 1.00 | CHRM2 (0.55) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL13748874 | 0.97 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL15591978 | 0.97 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL715461 | 0.97 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL2402964 | 0.97 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL720253 | 0.97 | CHRM2 (0.58) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL15591996 | 0.97 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL742297 | 0.97 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL711967 | 0.97 | CHRM2 (0.50) | CHRM2DNM1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025070707-A1 | COMPOSITION CONTAINING DIAMINE AND/OR POLYAMINE FOR PREVENTING OR IMPROVING FRAILTY | 東洋紡株式会社 | 2025-04-03 | — | — | WO | claimed |
| US-20220313625-A1 | PHARMACEUTICAL AGENT, MEDICINAL SOLUTION FOR CLEANING PULMONARY ALVEOLI, AND NEBULIZER | OHKIDO, MAKIKO (JP) | 2022-10-06 | — | — | US | claimed |
| US-10184129-B2 | Method and compositions to promote plant growth in metal contaminated environments | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-01-22 | — | — | US | claimed |
| EP-2486920-B1 | STRESS-ALLEVIATING AGENT COMPRISING PLANT-DERIVED POLYAMINE-CONTAINING EXTRACT AS ACTIVE INGREDIENT | TOYO BOSEKI (JP) | 2018-12-26 | — | — | EP | claimed |
| US-9115051-B2 | Method for producing polyamine composition from plant | TOYOBO CO., LTD. (JP) | 2015-08-25 | — | — | US | claimed |
| US-20140378708-A1 | METHOD FOR PRODUCING POLYAMINE COMPOSITION FROM PLANT | TOYOBO CO., LTD. (JP) | 2014-12-25 | — | — | US | claimed |
| US-20140213455-A1 | METHOD AND COMPOSITIONS TO PROMOTE PLANT GROWTH IN METAL CONTAMINATED ENVIRONMENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2014-07-31 | — | — | US | claimed |
| EP-2486920-A1 | STRESS-ALLEVIATING AGENT COMPRISING PLANT-DERIVED POLYAMINE-CONTAINING EXTRACT AS ACTIVE INGREDIENT | Toyo Boseki Kabushiki Kaisha (JP) | 2012-08-15 | — | — | EP | claimed |
| US-20110236512-A1 | STRESS-REDUCING AGENT INCLUDING PLANT-DERIVED POLYAMINE-CONTAINING EXTRACT SERVING AS ACTIVE COMPONENT | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2011-09-29 | — | — | US | claimed |
| EP-1001927-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003823-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 1999-01-28 | — | — | WO | claimed |
| WO-2025070707-A1 | COMPOSITION CONTAINING DIAMINE AND/OR POLYAMINE FOR PREVENTING OR IMPROVING FRAILTY | 東洋紡株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-20250001399-A1 | CELL ADSORPTION MATERIAL AND CELL ADSORPTION COLUMN | TORAY INDUSTRIES, INC. (JP) | 2025-01-02 | — | — | US | disclosed |
| EP-4427768-A1 | CELL ADSORPTION MATERIAL AND CELL ADSORPTION COLUMN | Toray Industries, Inc. (JP) | 2024-09-11 | — | — | EP | disclosed |
| WO-2023074729-A1 | CELL ADSORPTION MATERIAL AND CELL ADSORPTION COLUMN | 東レ株式会社 | 2023-05-04 | — | — | WO | disclosed |
| WO-2001092218-A2 | POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2001-12-06 | — | — | WO | disclosed |
| EP-1085011-A1 | Novel polyamine analogues as therapeutic and diagnostic agents | ORIDIGM CORPORATION (US) | 2001-03-21 | — | — | EP | disclosed |
| US-6172261-B1 | BIOSYNTHESIS USING CHAIN EXTENSION | ORIDIGM CORPORATION | 2001-01-09 | — | — | US | disclosed |
| EP-1001927-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003823-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 1999-01-28 | — | — | WO | disclosed |